ASHLEY WHEELER: Open Payments
NPI 1497401905 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 81 payments from 27 companies in 2025. Trend: 2023 $1,269 · 2024 $1,743 · 2025 $2,185
Food & beverage: $1,755Consulting: $430
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 5 | $501 |
| Novartis Pharmaceuticals Corporation | 12 | $236 |
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| Merck Sharp & Dohme LLC | 6 | $150 |
| Janssen Biotech, Inc. | 6 | $132 |
| Daiichi Sankyo Inc. | 6 | $130 |
| Emmaus Medical, Inc. | 5 | $108 |
| Genentech USA, Inc. | 4 | $95 |
| PFIZER INC. | 2 | $77 |
| Incyte Corporation | 3 | $72 |
Products named: FERRIPROX, KEYTRUDA, ENHERTU, Endari, KISQALI, Fabhalta, TALVEY, DATROWAY.
Industry payments across LA — which companies pay providers there.
